. Neuron-glial communication mediated by TNF-␣ and glial activation in dorsal root ganglia in visceral inflammatory hypersensitivity. Am J Physiol Gastrointest Liver Physiol 306: G788 -G795, 2014. First published March 13, 2014; doi:10.1152/ajpgi.00318.2013.-Communication between neurons and glia in the dorsal root ganglia (DRG) and the central nervous system is critical for nociception. Both glial activation and proinflammatory cytokine induction underlie this communication. We investigated whether satellite glial cell (SGC) and tumor necrosis factor-␣ (TNF-␣) activation in DRG participates in a 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced rat model of visceral hyperalgesia. In TNBS-treated rats, TNF-␣ expression increased in DRG and was colocalized to SGCs enveloping a given neuron. These SGCs were activated as visualized under electron microscopy: they had more elongated processes projecting into the connective tissue space and more gap junctions. When nerves attached to DRG (L6-S1) were stimulated with a series of electrical stimulations, TNF-␣ were released from DRG in TNBS-treated animals compared with controls. Using a current clamp, we noted that exogenous TNF-␣ (2.5 ng/ml) increased DRG neuron activity, and visceral pain behavioral responses were reversed by intrathecal administration of anti-TNF-␣ (10 g·kg Ϫ1 ·day Ϫ1 ). Based on our findings, TNF-␣ and SGC activation in neuron-glial communication are critical in inflammatory visceral hyperalgesia.
tumor necrosis factor-␣; satellite glial cells VISCERAL PAIN OF COLITIS OF inflammatory bowel disease (IBD) patients contributes significantly to morbidity and affects quality of life. Such pain is a clinical challenge because the mechanisms underlying it are unclear. Colonic inflammation is a major cause of chronic pain and may induce changes in visceral dorsal root ganglia (DRG). DRG occupies a unique position within the nociceptive pathway, since it is the first station where sensations are generated (7, 13, 17) . Inflammation at the level of the peripheral terminals can send nociceptive signals, which could alter DRG neuron behavior (17, 20, 36, 43) . Neuronal changes could contribute to processing the induction and maintenance of visceral pain (10, 20, 36, 37) . Satellite glial cells (SGCs) are the main type of glia in sensory ganglia, and these can proliferate under pathological conditions (21) , upregulating glial fibrillary acidic protein (GFAP) and interleukin-1␤ (25, 34) , augmenting intercellular coupling to increase gap junctions (5, 16, 19) as evidenced by upregulation of gap junction connexin 43 (33) , and altering electrophysiological properties (52) . Such changes suggest that glial cell activation in peripheral ganglia participates in nociception (4, 7, 8, 18, 44) . An important mechanism of visceral pain is that it can be activated by the neuronal excitation that occurs with inflammation, and in turn release proinflammatory cytokines that modulate neuronal excitability (47) . Therefore, the contribution of reciprocal communications between neurons and glia could reasonably amplify neuronal input, facilitating the maintenance of injury-induced pain (12, 29) . However, it is unclear whether and how SGCs are activated in DRG in the process of production and maintenance of visceral pain.
Tumor necrosis factor (TNF-␣), once recognized as a potent proinflammatory cytokine, has recently attracted considerable attention as a pain mediator. Increasing evidence suggests it has peripheral effects in nociception (23, 24, 35, 50, 51, 54) . TNF-␣ apparently plays a critical role in various types of pain, and application of TNF-␣ to normal or injured DRG produces persistent mechanical allodynia (6, 43) . TNF-␣ expression increased in DRG for which immunoreactivity has been detected in SGCs and neuronal bodies after neuropathic hyperalgesia (9, 40, 41) . Significantly increased TNF-␣ has been reported in supernatant samples from human IBD biopsies (20) . However, few studies have focused on the role of TNF-␣ in pathways conveying nociceptive information to the central nervous system (CNS) in inflammatory visceral hyperalgesia. Finally, morphological cellular and molecular evidence of changes in TNF-␣ in DRG associated with hyperalgesia has not been documented.
We propose that both activation of SGCs and changes of TNF-␣ in DRG participate in inflammatory visceral hyperalgesia. To test this idea, we induced an established rat model of inflammation hyperalgesia using colonic inflammation. We measured changes in TNF-␣ in DRG L 6 -S 2 and examined sensory neurons and SGCs. We observed that TNF-␣ release and SGC activation, establishing a neuron-glial communication in DRG, is involved in visceral nociception transduction.
MATERIALS AND METHODS

Animals and introduction of inflammatory visceral hyperalgesia.
Experiments were performed using adult male Sprague-Dawley (SD) rats (200 -250 g) from the Shanghai Center of Experimental Animals (CAS, Shanghai, China). Rats were group-housed in standard rodent cages at 24°C in a 12:12-h light-dark controlled room and allowed free access to food and water. All animal procedures carried out in this study were approved by Shanghai Jiao Tong University School of Medicine Animal Care and Use Committee and were in accordance with the Ethical Guidelines of the International Association for the Study of Pain (55) .
Colonic inflammation was induced by administration of a single dose of 2,4,6-trinitrobenzene sulfonic acid (TNBS) in ethanol as previously described (31) . Animals were anesthetized with pentobarbital (50 mg/kg ip) before colonic administration of TNBS. A Fogarty embolectomy catheter (3F; Edwards Lifesciences ALL, Irvine, CA) was used. Through this catheter, 40 mg of TNBS (Sigma-Aldrich, St.
Louis, MO) in 50% ethanol was instilled in the lumen, 5-6 cm from the anus. Controls received an equal volume of normal saline (NS). Experiments were then performed 4 days after colonic administration of TNBS.
Western blot. L 6-S2 DRG dissected from rats in both groups were homogenized on ice in RIPA buffer (Sigma) and protease inhibitor for protein extraction. Tissue sample aliquots were subjected to SDS-PAGE and transferred onto PVDF membranes (Bio-Rad Laboratories, Hercules, CA). Nonspecific binding sites were blocked with 5% nonfat milk for 1 h at room temperature. Next, membranes were incubated with anti-TNF-␣ (1:500; R&D Systems, Minneapolis, MN), and GAPDH (1:500, Novus Biologicals, Littleton, CO), overnight at 4°C, followed by incubation with the appropriate secondary antibodies (1:1,000) for 2 h at room temperature. The immunoreaction was detected with and ECL Western blotting kit (Amersham, San Francisco, CA).
Real-time PCR. Rats were terminally anesthetized with CO 2 and L 6-S2 DRG from those rats were rapidly removed and stored at Ϫ80°C. RNA was extracted from the frozen L 6-S2 DRG with TRIzol (Life Technologies, Carlsbad, CA). Next, 3 g of RNA from each tested sample were used for transcription in a total volume of 20 l. Oligo(dT) and Superscript II (Life Technologies) were applied to synthesized cDNA. Real-time PCR was performed in 25-l wells with the ABI Power SYBR Green PCR Master Mix (Life Technologies) with a 7300 Sequence Detection System (Life Technologies). PCR conditions were 50°C for 2 min and 95°C 10 min for the initiation of thermal cycling. The initial steps were then followed by 40 cycles of 95°C for 15 s for melting and 60°C for 1 min for annealing and extension. Each reaction was performed in triplicate. The cycle threshold (Ct) values of ␤-actin as a loading control were used to normalize each sample. PCR primers were as follows: 1) TNF-␣ (GenBank NM_012675) forward primer (5=-CTTCTGTCTACTGAACTTCG-3=) and reverse primer (5=-GTGCTT-GATCTGTTGTTTCC-3=); 2) ␤-actin (GenBank: NM_031144) forward primer (5=-TCAGTGTGGATTGGTGGCTCT-3=) and reverse primer (5=-AGAAGCATTTGCGGTGCAC-3=). The fold-changes in TNF-␣ mRNA transcript relative to ␤-actin were measured by ⌬Ct (Ct TNF-␣ Ϫ Ct ␤-actin). The relative amount of mRNA transcript in ganglia from TNBS-treated rats to controls was measured by 2
Ϫ⌬⌬Ct calculation,
Immunohistochemistry. Twelve Rats (6 controls and 6 treated) were deeply anesthetized with 1% pentobarbital sodium (50 mg/kg ip) and were perfused through the ascending aorta with saline followed by 4% paraformaldehyde in 0.1 mol/l phosphate buffer (PB), pH 7.2-7.4. The L6-S2 DRG were removed and postfixed for 4 h and then cryprotected in 30% sucrose in 0.1 mol/l PB overnight at 4°C. Ten-micrometer sections were cut on a cryostat and thaw mounted onto slides. Next, 30 -35 sections were taken from each DRG, and at least five DRG sections from each ganglion were analyzed to ensure the entire ganglion was viewed. All sections were blocked with 10% normal horse serum and 0.3% Triton X-100 for 1 h at room temperature. Tissue sections were incubated overnight at 4°C with anti-TNF-␣ (1:200; Santa Cruz Biotechnology, Dallas, TX) and anti-GFAP (1:200; EMD Millipore, Billerica, MA). After being washed with PBS, sections were then incubated with secondary FITC (1:200; Jackson ImmunoResearch, West Grove, PA) and Cy3 (1:200; Jackson ImmunoResearch)-conjugated second antibodies for 2 h at room temperature and washed again with PBS. Primary and secondary antibodies were diluted in PBS containing 1% bovine serum albumin and 0.3% Triton X-100. Positive controls were conducted in rat lung and skin, and negative controls were carried out in preabsorption experiments with cognate antigens. In every sample group, dark-field controls without primary antibody were included. Images of sections were obtained with an inverted microscope (IX-71; Olympus, Tokyo, Japan). Photomicrographic images were assembled using Adobe Photoshop fluorescence. Stained slides containing DRG were randomly selected, and sections from each ganglion were analyzed to evaluate the percentage of immune-positive cells.
Electron microscopy. Ten rats (5 controls and 5 TNBS-treated animals) were anesthetized with pentobarbital sodium and perfused transcardially with solution containing 2% glutaradehyde in 0.1 M PB (pH ϭ 7.4). The DRG L6-S2 were removed and fixed in the same solution overnight at 4°C. After being washed with cacodylate buffer for 2 h, DRG were postfixed on ice for 2 h in 2% OsO 4 buffered with 0.1 M sodium cacodylate (pH ϭ 7.2). Specimens were washed in distilled water, stained with 2% aqueous uranyl acetate, dehydrated in alcohol, and embedded in resin. Three semithin sections were prepared from each ganglion and stained with 0.5% toluidine blue in 1% sodium borate. Sections were examined under a light microscope to verify fixation quality, and the best preserved ganglia were used in subsequent analyses. Overall, 24 ganglia (12/group) were used for electron microscope visualization. Thin sections (ϳ60 nm) were cut from these ganglia and were examined under an electron microscope (Hitachi-7650). Each thin section (2.0 ϫ 0.15 mm 2 ) was photographed in its entirety at a magnification of ϫ7,500, and negatives were printed to a final magnification of ϫ30,000. Several thin sections, 30 m apart, were cut from the ganglia. The sectional area of the SGC sheath enveloping each nerve cell body was measured. A total of 158 SGC sheaths from control ganglia and 174 from treated ganglia was measured. Two parameters were measured in each section: the number of gap junctions occurring between SGC sheaths and the surface area occupied by SGC sheaths. Subsequently, the mean density of gap junctions was measured using the number of gap junctions per 100 m 2 of the section occupied by SGCs. Finally, a series (130 -140) of consecutive thin sections was cut from each of four ganglia (2 control and 2 TNBS-treated ganglia). The sections were organized in the same sequence as the serial orders. Altogether, 102 DRG neurons together with their SGC sheaths from control ganglia and 118 from treated ganglia were examined. The numbers and percentages of the SGC sheaths connected to each other were determined in both control and treated groups.
Whole cell patch-clamp recording in a primary culture of rat DRG neurons. Newborn rat DRG were removed and collected into chilled Hanks' balanced salt solution (Life Technologies). After dissection, trypsin/EDTA (0.25%; Life Technologies) was added to the media, and the ganglia were dissociated by enzymatic treatment for 25 min at 37°C with gentle agitation every 5 min. DRG were suspended in Dulbecco's modified Eagle's medium (Life Technologies) containing 10% fetal bovine serum (Life Technologies), 2 mmol/l glutamine, 100 U/ml penicillin, and 100 g/ml streptomycin. Individual cells were seeded on plastic poly-L-lysine (100 g/ml, P2636; Sigma)-coated cover slips in 30-mm petri dishes in a humidified incubator at 37°C, 95% air, and 5% CO2. Next, TNF-␣ (R&D Systems) was added to the medium 24 h later after seeding a final concentration of 2.5 ng/ml. The neurons were cultured in the presence of TNF-␣ for 4 days before electrophysiological studies. For action potential (AP) recordings, neurons were superfused with extracellular recording solution of the following composition (in mmol/l): 140 NaCl, 5.4 KCl, 1 CaCl2, 1 MgCl2, 10 HEPES, and 10 D-glucose, with pH adjusted to 7.30 using 1 mmol/l NaOH. The osmolarity of the extracellular and intracellular solution was 280 -310 mmol/kg (46) . To identify the effects of TNF-␣ on neuronal activity, parallel experiments on TNF-␣-treated neurons were performed in the extracellular solution with TNF-␣ antibody (anti-TNF-␣) added (4 g/ml). The patch electrode was filled with the intracellular solution composed of the following constituents (in mmol/l): 124 KCl, 1 EGTA, 10 HEPES, and 2 MgCl2, with pH adjusted to 7.25 with KOH. Just before the patch pipettes were filled, 4 mmol/l Mg-ATP and 0.3 mmol/l Na-GTP were added to the abovementioned solution (20) . All chemicals and drugs were obtained from Sigma-Aldrich. Whole cell patch recordings were performed using previously described methods of Qian's laboratory (36) . Briefly, a whole cell configuration was obtained from DRG neurons in the voltage-clamp mode. The recording began when a stable state was achieved under the current-clamp mode. The fast and slow capacitance and series resistance during the recordings were compensated electronically. Recordings were included in the study when cells had an access resistance Ͻ15 M⍀. All experiments were performed at room temperature (25-27°C). Signals were acquired using a computercontrolled amplifier (EPC10, USB; HEKA Elektronic), and data were recorded using a Pulse program (HEKA). During the current-clamp recordings, APs of DRG neurons were evoked by injection of a series of 200-ms depolarizing current pluses from Ϫ20 up to 400 pA with a 20-pA step increment. Only neurons with a steady resting membrane potential more negative than Ϫ45 mV were included in the study for data analysis.
Drug application and behavioral testing. Pentobarbital-anesthetized SD rats (200 -250 g) were implanted with a sterile polyethylene catheter (PE-10, 0.28 mm ID/0.61 mm OD). Intrathecal catheters were inserted through a needle laid close to the level of the lumbosacral enlargement. The injection process carried out was modified from methods previously described by Yaksh and Rudy (49) . After a 1-wk recovery period, all animals except those with motor abnormalities (fewer than 5% of the total number) were used for experiments. Monoclonal antibody anti-rat TNF-␣ (10 g·kg Ϫ1 ·rat Ϫ1 it; R&D Systems) or saline (10 l flushed with 10 l saline) was applied once a day for four consecutive days (50) from the TNBS treatment day. Behavioral tests were performed before and after the last injection of anti-rat TNF-␣ on the fourth day of TNBS treatment. Behavioral tests were assessed by measuring the abdominal withdrawal reflex (AWR) response to colorectal distention (CRD). The criteria were based on a semiquantitative score. When rats were mildly anesthetized by ether, a flexible latex balloon (5 cm) attached to the perforated end of an embolectomy catheter (LeMaitre Vascular, Burlington, MA) was placed (5-7 cm) in the rats' descending colons and secured. Next, rats were housed in small Lucite cubicles (20 ϫ 8 ϫ 8 cm) and allowed to wake up and adapt for half an hour. Measurements of each rat's response to CRD (20, 40, 60 and 80 mmHg) were made by three observers, and then AWR scores were assigned. CRDs were performed for 20 s at a constant pressure with 2-min interstimulus rest and repeated three times for each pressure intensity. The visceral pain threshold indicated was defined as the first nociceptive response as previously described (2) . The mean data of nociceptive thresholds for all treatment groups were averaged for analysis.
Isolation and identification of distal colon projecting DRG neurons and patch-clamp recording. Colon specific DRG neurons were labeled by injection of 1,1==-dioleyl-3,3,3==,3==-tetramethylindocarbocyanine methane sulfonate (Dil; Invitrogen) into the colon wall, as described previously (36) . After 1 wk of Dil labeling, TNBS colitis was induced, and its administration was performed as described above. Colonic DRG neurons from three groups (control, TNBS, TNBS ϩ anti-TNF-␣) were used for recording 4 days later. Isolation of DRG neurons from these adults SD rats has been described previously (30) . Briefly, DRG were digested with 0.2 mg/ml papain (Sigma) activated with 0.4 mg/ml collagenase (Sigma) and 4 mg/ml dispase II, and mechanically dissociated. DRG neurons were grown in a neurobasal-based medium for 24 h before use. For current-clamp recording, the cells were held at Ϫ60 mV, and the firing threshold of DRG neurons was first measured by a series of 100-ms depolarizing currents in 5-pA steps from 0 pA to elicit the first AP. To further examine neuronal firing properties, a large depolarizing current injection of 400 ms, 600 pA was delivered to elicit firing from the cells. In our present study, a depolaring current pulse (400 ms, 600 pA) was injected into neurons, and the firing frequency was analyzed among the groups.
Statistical analysis. Data were expressed as means Ϯ SE and were analyzed using Student's t-test for comparison between the two groups, or one-way ANOVA followed by Dunnett's posttest. Statistical analyses were performed using Prism 5.01 software (GraphPad Software, La Jolla, CA). A P value Յ0.05 was considered statistically significant.
RESULT
Expression of TNF-␣ in L 6 -S 2 DRG.
To determine whether TNF-␣ contributes to the visceral hypersensitivity in TNBStreated rats, we measured TNF-␣ mRNA and protein expression in L 6 -S 2 DRG. Based on the C t values, we calculated TNF-␣ at the gene level. TNF-␣ mRNA was increased in TNBS-treated rats compared with the control (TNBS vs. control: 1.00 Ϯ 0.1352 vs. 1.493 Ϯ 0.2675; n ϭ 6; P ϭ 0.0024; Fig. 1A ). The upregulation of TNF-␣ was also quantified by Western blot analysis. Total proteins were extracted from the same segments of isolated DRG. As shown in Fig. 1B , protein expression of TNF-␣ in L 6 -S 2 from TNBS-treated rats was higher than that from the controls (TNBS vs. control: 1.941 Ϯ 0.1839 vs. 1.054 Ϯ 0.8249; n ϭ 8; P ϭ 0.0117), which were consistent with mRNA expression levels.
Location of upregulated TNF-␣ in DRG and SGC activation. Immunohistochemical analysis revealed an increase in TNF-␣ in DRG from the TNBS-treated group. Increased TNF-␣ mainly localized around a given neuron and colocalized with GFAP immunoreactive SGCs ( Fig. 2A) . A stronger immunoreactivity for GFAP was also observed in the TNBS-treated group (Fig. 2, A and B) . To examine SGC activation in the process, we then studied the ultrastructure of SGCs in the DRG using electron microscopy and observed that, in ganglia from TNBS-treated rats, more elongated processes extended from the SGC sheath and projected into the connective tissue space. In control ganglia the SGC sheath enveloping a given neuron had a rather smooth outer contour (Fig. 2C) . In both ganglia from control and TNBS-treated rats, we examined a total surface area occupied by SGCs of 5,000 m 2 (Fig. 2D) . In the sections, gap junctions were apparent between SGCs, and most then occurred singly. The mean density of gap junctions was two times greater in the treated group than in controls (TNBS vs. control: 0.6030 Ϯ 0.1069 vs. 0.2997 Ϯ 0.0935, n ϭ 5; P ϭ 0.0439). The density of gap junctions was calculated as the number of junctions per unit of surface area (100 m 2 ) occupied by SGCs.
Release of TNF-␣ during stimulation increase in TNBStreated rats. Neurons and SGCs in DRG have communication pathways: SGCs can release cytokines to alter neuron excitability. Thus, to learn whether upregulated TNF-␣ in SGCs of TNBS-treated rats can be released with afferent fiber stimulation, we applied electrical stimulation to afferent fibers attached to DRG (Fig. 3A) . Under tetanic nerve stimulation, a condition mimicking pronociception in sensory neurons, measurements of TNF-␣ before (C 0 ) and after stimulation (C 1 ) were made. TNF-␣ in artificial cerebrospinal fluid was not different between the two groups before stimulation (TNBS vs. control: 4.602 Ϯ 1.120 pg/ml, n ϭ 6 vs. 5.599 Ϯ 1.630 pg/ml, n ϭ 7; P ϭ 0.2334; Fig. 3B ). However, after tetanic trains of stimulation, TNF-␣ release (C release ϭ C 1 Ϫ C 0 ) increased significantly in TNBS-treated rats compared with controls (TNBS vs. control: 4.185 Ϯ 0.9284 pg/ml, n ϭ 6 vs. 1.230 Ϯ 0.5882 pg/ml, n ϭ 7; P ϭ 0.0255). These data indicate that, with the same stimulation, TNF-␣ release from DRG was greater in rats treated with TNBS.
TNF-␣ increases the excitability of rat DRG neurons. To study the influence to neuronal activity on TNF-␣ release, neonatal rat DRG neurons were cultured with TNF-␣ for 4 days, a condition simulating cellular response to long-term inflammation. We examined the current threshold (rheobase) and pattern of firing in response to depolarizing current stimulation in TNF-␣-treated neurons. In the study, neurons incubated with low concentrations of TNF-␣ (2.5 ng/ml) had decreased rheobase (82.00 Ϯ 12.45 pA, n ϭ 11) compared with those cultured in the control media (124.30 Ϯ 12.08 pA, n ϭ 9; P ϭ 0.0264). These differences were not significant, however, when anti-TNF-␣ (2 g/ml) was added to the extracellular solution (121.5 Ϯ 9.99 pA, n ϭ 9, P Ͼ 0.05; Fig. 4, A  and B) . Meanwhile, the number of APs in response to current stimulation (2 ϫ rheobase) was also examined, and the number of spikes elicited at two times the rheobase was significantly increased in DRG neurons in the presence of TNF-␣ (TNF-␣: 27.78 Ϯ 2.183 Hz, n ϭ 8; P Ͻ 0.01), whereas the firing of TNF-␣-treated neurons was not potentiated at two times the rheobase in the presence of anti-TNF-␣ (anti-TNF-␣: 8.556 Ϯ 1.792 Hz, n ϭ 11, P Ͼ 0.05) compared with controls (control: 5.556 Ϯ 1.085 Hz, n ϭ 9; Fig. 4, A and C) . With low TNF-␣ or anti-TNF-␣ concentrations, the resting membrane potential was not significantly different among the three group (control: Ϫ54.40 Ϯ 0.9092 mV, n ϭ 9; TNF-␣: Ϫ53.67 Ϯ 0.8175 mV, n ϭ 8; anti-TNF-␣: 54.07 Ϯ 0.9022 mV, n ϭ 8; P ϭ 0.6553), which confirmed that all neuron groups were under the physiological status.
Intrathecal administration of antibody against TNF-␣ reduced the visceral hypersensitivity. Visceral sensitivity was measured using the AWR scores in response to CRD on the 4th day after TNBS intracolonic administration. In agreement with previously reported data, TNBS-treated rats had greater mean AWR scores at all distension pressures than NS-treated rats (20 mmHg: P Ͻ 0.0001; 40 mmHg: P ϭ 0.0003; 60 mmHg: P Ͻ 0.0001; 80 mmHg: P ϭ 0.0059; Fig. 5A ). To evaluate whether endogenous TNF-␣ contributes to the development hyperalgesia, we then examined the change in response to CRD after administration of anti-TNF-␣ for 4 days. The anti-TNF-␣ dose (10 g/kg) selected was based upon previous in vivo studies (3) . In viscerally sensitized rats, anti-TNF-␣ intrathecal treatment reduced mean AWR sores to CRD at 20, 40, and 60 mmHg when compared with NS intrathecal treatment (anti-TNF-␣ it vs. NS it: 20 mmHg, 1.0 Ϯ 0.2952 vs. 1.815 Ϯ 0.27, Fig. 3 . The TNF-␣ release of DRG from TNBS-treated rats was significantly increased after prolonged tetanic stimulation. A: tetanic stimulation protocol. B: nerve stimulation increases release of TNF-␣ in DRG of TNBS-treated rats. Release of TNF-␣ from DRG markedly increased in rats treated with TNBS after tetanic trains of stimulation (Crelease ϭ C1 Ϫ C0, where C0 is the measurement of TNF-␣ before stimulation and C1 is the measurement of TNF-␣ after stimulation; TNBS vs. control: 4.185 Ϯ 0.9284 pg/ml, n ϭ 6 vs. 1.230 Ϯ 0.5882 pg/ml, n ϭ 7; *P Ͻ 0.05). Fig. 5B ). Anti-TNF-␣ had no significant effects at a distension of 80 mmHg (anti-TNF-␣ it vs. NS it: 3.890 Ϯ 0.6957 vs. 3.835 Ϯ 0.7379; n ϭ 8, P ϭ 0.5995). Thus, a single anti-TNF-␣ intrathecal treatment decreased the pain response, suggesting that TNF-␣ has a specific role in visceral sensitivity in TNBS-treated rats. Meanwhile, the intrathecal administration of NS to TNBS-treated rats did not change the withdrawal response compared with corresponding TNBStreated groups, suggesting an absence of the effect from the chronic implanted catheter.
We also investigated whether alterations in visceral hypersensitivity were associated with changes in excitability in DRG neurons. To do so, we examined the isolated neurons in rats under a current clamp. As shown in Fig. 6 , significantly more APs fired in DRG neurons evoked by a constant (400 ms, 600 pA) depolarizing current pulse with intracolonic administration of TNBS. The firing frequency of evoked APs was not potentiated in TNBS-treated rats if the anti-TNF-␣ was given intrathecally for 4 days (control: 5.556 Ϯ 1.085 Hz, n ϭ 10; TNBS: 27.78 Ϯ 2.183 Hz, n ϭ 9; TNBS ϩ anti-TNF-␣ it: 8.556 Ϯ 1.792 Hz, n ϭ 9; P Ͻ 0.01).
DISCUSSION
The data generated here suggest that TNF-␣ and SGC activation in DRG, in a model of TNBS-induced colonic inflammation, is integral to visceral hyperalgesia. We observed TNF-␣ expression was increased and mainly localized in SGCs in DRG and that these SGCs were activated. Immunosorbent assay data showed that, when the DRG afferent fiber was stimulated, upregulated TNF-␣ was released to a greater extent in TNBS-treated rats. In addition, exogenously applied TNF-␣ increased excitability of DRG neurons. Thus, TNF-␣ and activation of SGCs play important roles in inflammatory visceral hyperalgesia, likely because of neuron-glia and glia-glia communication enhancement during the process.
Our data offer new information about the possible contribution of SGC activation to visceral pain. Studies are increasingly indicating that the role of glia in central sensitization contributes to visceral hyperalgesia in various animal models (11) . Spinal glia activation was found to be responsible for visceral hyperalgesia (1, 27, 39) . Microglial activation was also found in the hippocampus in models of visceral hyperalgesia induced by intracolonic administration of TNBS (38) . In contrast to the progress made with CNS glia, little is known about SGCs in visceral pain. In this study, we provide evidence that, in the inflammatory visceral pain model, SGCs in DRG were activated, including SGC immunoreactivity for GFAP, and the alteration occurred in the ultrastructure with electron microscopy. The electron microscopic study showed that more processes extend from SGCs into connective tissue space and the number of gap junction-mediated couplings among SGCs increased more than twofold in TNBS-treated rats.
Given that colonic inflammation leads to SGC activation, we propose that the augmentation of SGC coupling by gap junctions also participates in the activation process. The function of this coupling is not clear, but it could be that augmented glial coupling increases the ability of these cells to buffer higher K ϩ extracellular concentrations produced by greater nerve firing (45) . Clearly more work needs to be done on the apparently opposed aspects of glial coupling, their relation to glial activation, and their role in inflammatory visceral pain.
Little is known about the signaling mechanism between peripheral inflammation and SGC activation, but there is speculation that upregulation of TNF-␣ is part of the activation of SGCs after hyperalgesia. According to our data that TNF-␣ in DRG was increased in TNBS-treated rats, we identified the location of upregulated TNF-␣ and learned whether upregulated TNF-␣ might influence the progress of visceral hyperal- Fig. 6 . Excitability of DRG neurons from control and TNBStreated rats. A: representative traces of action potentials (APs) elicited by 400-ms 600-pA pulse in a control neuron. B: representative traces of APs elicited in a neuron from TNBS-treated rats it administered NS. C: representative traces of APs elicited in neurons from TNBS rats it administered anti-TNF-␣. D: histogram of the number of spikes elicited of control, TNBS, and TNBS ϩ anti-TNF-␣ it groups (control: 5.556 Ϯ 1.085 Hz, n ϭ 10; TNBS: 27.78 Ϯ 2.183 Hz, n ϭ 9; TNBS ϩ anti-TNF-␣ it: 8.556 Ϯ 1.792 Hz, n ϭ 9; **P Ͻ 0.01).
gesia. In an inflammatory visceral pain model TNF-␣ significantly increased and was mainly located within SGCs. However, the cause and effect between the upregulation of TNF-␣ in SGCs and the activation of SGCs is unclear. Perhaps the regulation of TNF-␣ is one form of activation in SGCs.
SGCs are known to tightly enwrap the neuronal somata to form a structural and functional unit in DRG (15) . Several studies suggest that glial cells in those units might release factors that regulate neuronal function (28) . We proposed TNF-␣ upregulated in SGCs might be released, change neuronal surrounding, and finally act on neurons. In our study this speculation was confirmed with data that show that, after tetanic trains of stimulation to spinal nerve-attached DRG, TNF-␣ increased significantly in the TNBS-treated group. To determine the consequence of TNF-␣ released form SGCs, we studied the action of exogenously added TNF-␣ on neuronal activity.
Application of TNF-␣ increases the excitability of dissociated DRG neurons and perhaps the increased release of TNF-␣ from the SGCs after stimulation then exerts pronociceptive actions on sensory neuronal activity. Evidence exits that TNF-␣ can alter behavior of sensory neurons, exogenously applied TNF-␣ depolarized and increased DRG neuron excitability (26, 53) , and human TNF-␣ derived from supernatant from biopsies of human ulcerative colitis induced hyperexcitability of nociceptive neurons innervating the colon (20) . In accordance with previous study, our data reveal that cultivation with TNF-␣ for 4 days increased the excitability of dissociated DRG neurons, and this effect could be reversed by TNF-␣ antagonism. Moreover, we found the average firing frequency of DRG neurons were potentiated in TNBS-treated rats. Intrathecally blocking the TNF-␣ decreased DRG neuron excitability. The mechanisms of TNF-␣ action may include acting on TNF-␣ receptor 1 (48), reducing voltage-dependent K ϩ currents, enhancing tetrodotoxin Na ϩ channels (20, 22) , increasing capsaicin response (32) , and then sensitizing voltageactivated calcium channels (14) , potentiating the P2X3 receptor (53) , and promoting the TNF-p38 signal transduction cascade in DRG (41) . Evidence suggests that these changes are not intrinsic events of neurons but rather depend on other cells (42) . Thus, TNF-␣ released from SGCs may increase neuron excitability, which means that the neuron-glial relationship is created in DRG during the generation of sensation.
In our study TNF-␣ established a relationship, or rather a communication, between glia and neurons. The communication doubtlessly contributed to exaggerated responses under pathological conditions. Mechanisms by which the complex, two-way communication between glia and neurons contribute to primary sensory ganglion-dependent nociception have been studied (13) . In the present study we believed that TNF-␣ will emerge as an important participant in the process.
Our results emphasized the importance of SGC activation and TNF-␣-mediated neuron-glial communication in the primary ganglion, and our work confirms the presence of pronounced antinociceptive effects of blocking communication between neurons and glial cells by TNF-␣ neutralization in a model of IBD. This effect resulted from a neuronal site of action rather than from a reduction of inflammation. Taken together these data suggest that the communication may play a role in pain and open a range of new possibilities for curing visceral inflammatory pain.
